SAMANTHA FALKOWSKI: Open Payments
NPI 1659942902 · FRAMINGHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$392 in 11 payments from 5 companies in 2025. Trend: 2023 $91 · 2024 $595 · 2025 $392
Food & beverage: $392
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $265 |
| GENZYME CORPORATION | 1 | $39 |
| Madrigal Pharmaceuticals | 1 | $36 |
| Lilly USA, LLC | 1 | $32 |
| Novo Nordisk Inc | 1 | $20 |
Products named: TREMFYA, DUPIXENT, REZDIFFRA, OMVOH, Wegovy.
Industry payments across MA — which companies pay providers there.
